Cargando…
Translating the Symptom Screening in Paediatrics Tool (SSPedi) into North American Spanish and Among Spanish-speaking children receiving cancer treatments: evaluating understandability and cultural relevance in a multiple-phase descriptive study
OBJECTIVES: Symptom screening is important to achieving symptom control. Symptom Screening in Paediatrics Tool (SSPedi) is validated for English-speaking children. Objectives were to translate SSPedi into Spanish, and to evaluate the understandability and cultural relevance of the translated version...
Autores principales: | Plenert, Erin, Grimes, Allison, Sugalski, Aaron, Langevin, Anne-Marie, Nieto, Dominica, Salaverria, Carmen, Gomez, Sergio, Gonzalez, Gisela, D'Angelo, Gisela, Dupuis, Lee, Sung, Lillian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662419/ https://www.ncbi.nlm.nih.gov/pubmed/33184077 http://dx.doi.org/10.1136/bmjopen-2020-037406 |
Ejemplares similares
-
Translating the Symptom Screening in Pediatrics Tool (SSPedi) into Argentinian Spanish for paediatric patients receiving cancer treatments, and evaluating understandability and cultural relevance in a multiple-phase descriptive study
por: Gomez, Sergio, et al.
Publicado: (2021) -
Translation of the Pediatric Nausea Assessment Tool (PeNAT) Into
Spanish and Evaluating Understandability Among Spanish-Speaking Hispanic
American Children and Adolescents Receiving Chemotherapy
por: Garcia Frausto, Erica, et al.
Publicado: (2021) -
Translating the Symptom Screening in Pediatrics Tool (SSPedi) into French and among French-speaking children receiving cancer treatments, evaluating understandability and cultural relevance in a multiple-phase descriptive study
por: Larouche, Valérie, et al.
Publicado: (2020) -
Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7 years receiving cancer treatments
por: Tomlinson, Deborah, et al.
Publicado: (2022) -
Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments
por: Tomlinson, Deborah, et al.
Publicado: (2019)